10.19

0.00% 0.00

Drugs Made In America Acquisition Ii Corp (DMII)

Overview News Price History Financials Discussions Forecast

Drugs Made In America Acquisition Ii Corp stock is traded at $10.19, with a volume of 118.30K. It is up +0.00% in the last 24 hours and up +0.20% over the past month. Drugs Made In America Acquisition II Corp is a blank check Company.

Previous Close:

$10.19

Open:

$10.19

24h Volume:

118.30K

Relative Volume:

0.48

Market Cap:

$649.10M

Revenue:

Net Income/Loss:

$8.58M

P/E Ratio:

76.04

EPS:

0.134

Net Cash Flow:

$-1.11M

1W Performance:

+0.00%

1M Performance:

+0.20%

6M Performance:

+1.90%

1Y Performance:

+0.00%

1-Day Range:

$10.18

$10.19

1-Week Range:

$10.19

$10.20

52-Week Range:

$9.86

$10.33

Drugs Made In America Acquisition Ii Corp Stock (DMII) Company Profile

Name

Drugs Made In America Acquisition Ii Corp

Sector

Financial (7354)

Industry

Shell Companies (308)

Phone

954-870-3104

Address

420 LEXINGTON AVENUE, NEW YORK

Employee

Twitter

Next Earnings Date

null

Latest SEC Filings

DMII's Discussions on Twitter

Compare DMII vs VYLR, CCXI, EVAC, BCSS

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DMII Drugs Made In America Acquisition Ii Corp	10.19	649.10M	0	8.58M	-1.11M	0.134
VYLR Vylor Inc.	74.41	49.65B	0	0	0	0.00
CCXI Churchill Capital Corp Xi	10.86	604.90M	37.20M	-133.09M	-26.53M	0.0647
EVAC Eqv Ventures Acquisition Corp Ii	10.30	602.31M	0	12.80M	-714.00K	0.2184
BCSS Bain Capital Gss Investment Corp	10.22	596.85M	0	8.29M	-686.50K	0.142

Drugs Made In America Acquisition Ii Corp Stock (DMII) Latest News

Oct 08, 2026

DMII 8-K & SEC Filings - Yahoo Finance Australia

Oct 08, 2026

Oct 06, 2026

DMAA Stock Holds Near $10.89 as Acquisition Corp. Trades in Tight BandOutside Reversal - https://www.dars.gov.et/

Oct 06, 2026

Oct 05, 2026

DMIIU Holds Steady at $10.20 as Drugs Made In America Acquisition II Unit Trades FlatBreakout Stock Alerts - https://www.dars.gov.et/

Oct 05, 2026

Sep 18, 2026

HVMC Stock Price, Quote & News - Syfe

Sep 18, 2026

Sep 17, 2026

Drugs (DMII) Stock Alert: Dead Money at $10.16 — Or Is It? 2026-09-17Break of Structure - dars.gov.et

Sep 17, 2026

Drugs (DMII) Stock Alert: Dead Money at $10.16 — Or Is It? 2026-09-17Spring Pattern - dars.gov.et

Sep 17, 2026

Sep 15, 2026

Starton Therapeutics Appoints Experienced Finance Executive Saleem Elmasri, CPA, as Chief Financial Officer - The Manila Times

Sep 08, 2026

Sep 02, 2026

Drugs Made In America Acquisition II (DMII) Holds at $10.15 as SPAC Shares Trade Flat Within RangeValue Area Low - dars.gov.et

Sep 02, 2026

Drugs Made In America Acquisition II (DMII) Holds at $10.15 as SPAC Shares Trade Flat Within RangeQuality ETF - careplusvn.com

Sep 02, 2026

Sep 01, 2026

RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring's Rebyota® and Clenpiq® - PR Newswire

Sep 01, 2026

Aug 25, 2026

Drugs Made In America Acquisition (NASDAQ:DMAA) Shares Down 0%Should You Sell? - MarketBeat

Aug 25, 2026

Aug 22, 2026

Drugs (DMIIU) Momentum: Ends Little Changed at $10.20 in the Latest Reading; Immediate View: the Supplied Trading Band Runs From $9.69 to $10.71 under the Current SnapshotMomentum Breakout Ideas - siam.in

Aug 22, 2026

Aug 20, 2026

Drugs (DMII): Closes 0.20% Higher at $10.14 in Latest Trading; Chart Watch: $9.63 and $10.65 Define the Nearby Reference Levels in Latest TradingBuy Signal Reports - vinanet.vn

Aug 20, 2026

Drugs (DMII) Momentum: Ends Up by 0.10% at $10.13 in the Current Update; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance in the Latest SessionMarket Neutral Pair - vinanet.vn

Aug 20, 2026

Drugs Made In America Acquisition Corp. (DMAA) Stock Price, Chart, News & Analysis - Securities.io

Aug 20, 2026

Drugs (DMII): Closes 0.20% Higher at $10.14 in Latest Trading; Chart Watch: $9.63 and $10.65 Define the Nearby Reference Levels in Latest TradingProfitability Factor - careplusvn.com

Aug 20, 2026

Drugs (DMII) Momentum: Ends Up by 0.10% at $10.13 in the Current Update; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance in the Latest SessionPCR Divergence - careplusvn.com

Aug 20, 2026

Drugs (DMII) Momentum: Ends Up by 0.10% at $10.13 in the Current Update; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance in the Latest SessionBuyback Factor - dars.gov.et

Aug 20, 2026

Aug 18, 2026

Drugs (DMIIR) Daily Review: Closes with Little Net Change at $0.10 in Latest Trading; Level-Based View: the Current Price Sits Inside the Supplied Technical Range at the CloseMerger Arbitrage - Vinanet

Aug 18, 2026

Aug 16, 2026

DMII Holds at $10.13: Drugs Made In America Acquisition II Corp. Trades Flat Amid SPAC Market ConsolidationAdvance Decline Volume - dars.gov.et

Aug 16, 2026

DMII Holds at $10.13: Drugs Made In America Acquisition II Corp. Trades Flat Amid SPAC Market ConsolidationDark Pool Sentiment - dars.gov.et

Aug 16, 2026

Aug 14, 2026

Drugs Made In America Acquisition II (DMII) Earnings Date and Reports 2026 - MarketBeat

Aug 14, 2026

DMII Holds Steady at $10.13 as Acquisition Vehicle Trades in Tight RangeGamma Exposure - vinanet.vn

Aug 14, 2026

Drugs Made In America II (DMII) earns $8.7M but warns on going concern - Stock Titan

Aug 14, 2026

Drugs Made In America Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 14, 2026

Karpus Management (DMAA) discloses 10.33% beneficial stake in SPAC - Stock Titan

Aug 14, 2026

Drugs Made In America (DMAA): First Trust funds disclose 3.24% beneficial stake - Stock Titan

Aug 14, 2026

DMAA Holds at $10.69 as SPAC Awaits Definitive Acquisition TargetPCR Moving Average - vinanet.vn

Aug 14, 2026